20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Classical and intermediate monocytes scavenge non-transferrin-bound iron and damaged erythrocytes

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Myelomonocytic cells are critically involved in iron turnover as aged RBC recyclers. Human monocytes are divided in 3 subpopulations of classical, intermediate, and nonclassical cells, differing in inflammatory and migratory phenotype. Their functions in iron homeostasis are, however, unclear. Here, we asked whether the functional diversity of monocyte subsets translates into differences in handling physiological and pathological iron species. By microarray data analysis and flow cytometry we identified a set of iron-related genes and proteins upregulated in classical and, in part, intermediate monocytes. These included the iron exporter ferroportin (FPN1), ferritin, transferrin receptor, putative transporters of non-transferrin-bound iron (NTBI), and receptors for damaged erythrocytes. Consequently, classical monocytes displayed superior scavenging capabilities of potentially toxic NTBI, which were augmented by blocking iron export via hepcidin. The same subset and, to a lesser extent, the intermediate population, efficiently cleared damaged erythrocytes in vitro and mediated erythrophagocytosis in vivo in healthy volunteers and patients having received blood transfusions. To summarize, our data underline the physiologically important function of the classical and intermediate subset in clearing NTBI and damaged RBCs. As such, these cells may play a nonnegligible role in iron homeostasis and limit iron toxicity in iron overload conditions.

          Abstract

          Abstract

          Human classical and intermediate monocytes mediate clearance of non-transferrin-bound iron and erythrophagocytosis.

          Related collections

          Most cited references65

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          The fate and lifespan of human monocyte subsets in steady state and systemic inflammation

          Using stable isotope labeling, Patel et al. establish the lifespan of all three human monocyte subsets that circulate in dynamic equilibrium; in steady state, classical monocytes are short-lived precursors with the potential to become intermediate and nonclassical monocytes. They highlight that systemic inflammation induces an emergency release of classical monocytes into the circulation.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.

            Hypoferremia is a common response to systemic infections or generalized inflammatory disorders. In mouse models, the development of hypoferremia during inflammation requires hepcidin, an iron regulatory peptide hormone produced in the liver, but the inflammatory signals that regulate hepcidin are largely unknown. Our studies in human liver cell cultures, mice, and human volunteers indicate that IL-6 is the necessary and sufficient cytokine for the induction of hepcidin during inflammation and that the IL-6-hepcidin axis is responsible for the hypoferremia of inflammation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The three human monocyte subsets: implications for health and disease.

              Human blood monocytes are heterogeneous and conventionally subdivided into two subsets based on CD16 expression. Recently, the official nomenclature subdivides monocytes into three subsets, the additional subset arising from the segregation of the CD16+ monocytes into two based on relative expression of CD14. Recent whole genome analysis reveal that specialized functions and phenotypes can be attributed to these newly defined monocyte subsets. In this review, we discuss these recent results, and also the description and utility of this new segregation in several disease conditions. We also discuss alternative markers for segregating the monocyte subsets, for example using Tie-2 and slan, which do not necessarily follow the official method of segregating monocyte subsets based on relative CD14 and CD16 expressions.
                Bookmark

                Author and article information

                Contributors
                Journal
                JCI Insight
                JCI Insight
                JCI Insight
                JCI Insight
                American Society for Clinical Investigation
                2379-3708
                18 April 2019
                18 April 2019
                18 April 2019
                : 4
                : 8
                : e98867
                Affiliations
                [1 ]Department of Internal Medicine II,
                [2 ]Department of Internal Medicine V, and
                [3 ]Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria.
                [4 ]Department of Oncology, Amgen Inc., Thousand Oaks, California, USA.
                Author notes
                Address correspondence to: Piotr Tymoszuk, Medical University of Innsbruck, Department of Internal Medicine II, Anichstrasse 35, A-6020 Innsbruck, Austria. Phone: 43.512.504.25606; Email: piotr.tymoszuk@ 123456i-med.ac.at .
                Author information
                http://orcid.org/0000-0003-2265-1974
                http://orcid.org/0000-0003-0709-2158
                http://orcid.org/0000-0002-0398-6034
                Article
                98867
                10.1172/jci.insight.98867
                6538345
                30996139
                4c13e886-6919-4d78-a434-a43fca522c08
                © 2019 Haschka et al.

                This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 27 November 2017
                : 14 March 2019
                Funding
                Funded by: Austrian Research Fund (FWF)
                Award ID: P 28302
                Funded by: Austrian Research Fund (FWF)
                Award ID: W1253 HOROS
                Funded by: Österreichische Krebshilfe Tirol
                Award ID: 15024
                Funded by: Austrian Academy of Science (ÖAW)
                Award ID: DOC Fellowship
                Funded by: Austrian Research Fund
                Award ID: Epicross-33210
                to Igor Theurl
                to Günter Weiss and Verena Petzer
                to Piotr Tymoszuk
                to Günter Weiss
                Categories
                Research Article

                immunology,metabolism,innate immunity,monocytes
                immunology, metabolism, innate immunity, monocytes

                Comments

                Comment on this article